ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp., trading under the ticker ARYA, is a life sciences and biotechnology-focused special purpose acquisition company that completed its initial public offering in 2020. The vehicle was sponsored by Perceptive Advisors, a New York-based investment firm with a long track record in healthcare and life sciences investing. The company filed an 8-K with the Securities and Exchange Commission on March 17, 2020, under accession number 0001193125-20-075542. ARYA Sciences targeted acquisition opportunities in the broader life sciences sector, reflecting Perceptive Advisors' established expertise in identifying and backing emerging biotechnology companies. Sign up for a free SpacDesk account to access the full filing history, timeline, and deal data for ARYA Sciences Acquisition Corp. and hundreds of other SPACs.